The discrepancies between these studies and the current one may be attributed to two reasons: (1) The subcutaneous injection of insulin in this study has limitations, as it can easily lead to hypoglycemia and increase the risk of cognitive impairment in patients. Here, INS is linked to Cognitive impairment.